-+ 0.00%
-+ 0.00%
-+ 0.00%

60 Degrees Pharma signs exclusive Florida State University patent license for Australian chestnut extract supplement use

PUBT·06/11/2026 12:04:45
Listen to the news
60 Degrees Pharma signs exclusive Florida State University patent license for Australian chestnut extract supplement use
  • 60 Degrees Pharmaceuticals signed an exclusive patent license with Florida State University for non-prescription uses of Australian Chestnut Extract.
  • License supports large-scale extraction and purification of castanospermine from Castanospermum australe seeds, a key input for a botanical supplement product.
  • FDA issued a non-notification letter on the company’s New Dietary Ingredient Notification; an FDA meeting is set for July 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606110803PRIMZONEFULLFEED9735135) on June 11, 2026, and is solely responsible for the information contained therein.